Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study

Author： Takahashi Takao  

Publisher： Springer Publishing Company

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.18, Iss.2, 2013-04, pp. : 335-342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Percutaneous laser ablation in patients with isolated unresectable liver metastases from colorectal cancer: Results of a phase II study

By Pacella Claudio   Valle Dario   Bizzarri Giancarlo   Pacella Sara   Brunetti Maurizio   Maritati Raffaele   Osborn John   Stasi Roberto  

Acta Oncologica, Vol. 45, Iss. 1, 2006-02 ,pp. : 77-83

Informa Healthcare

Access to resources Recommend Favorite

Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: A multicenter phase II study by the cancer therapeutic research group

By Ho Wing   Ma B.   Mok Tony   Yeo W.   Lai Paul   Lim R.   Koh Jane   Wong Y.   King Ann   Leow C.   Chan A.  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 303-312

Humana Press, Inc

Access to resources Recommend Favorite

A Phase I Study of Hyperthermic Isolated Hepatic Perfusion with Oxaliplatin in the Treatment of Unresectable Liver Metastases from Colorectal Cancer

By Zeh Herbert   Brown Charles   Holtzman Matthew   Egorin Merrill   Holleran Julianne   Potter Douglas   Bartlett David  

Annals of Surgical Oncology, Vol. 16, Iss. 2, 2009-02 ,pp. : 385-394

Springer Publishing Company

Access to resources Recommend Favorite

A Randomized Phase II Trial of Three Intensified Chemotherapy Regimens in First-Line Treatment of Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases. The METHEP Trial

By Ychou Marc   Rivoire Michel   Thezenas Simon   Quenet François   Delpero Jean-Robert   Rebischung Christine   Letoublon Christian   Guimbaud Rosine   Francois Eric   Ducreux Michel   Desseigne Françoise   Fabre Jean-Michel   Assenat Eric  

Annals of Surgical Oncology, Vol. 20, Iss. 13, 2013-12 ,pp. : 4289-4297

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial Alternating FOLFOX-6 and FOLFIRI Regimens in Second-Line Therapy of Patients with Metastatic Colorectal Cancer (FIREFOX Study)

By Hebbar Mohamed   Tournigand Christophe   Lledo Gérard   Mabro May   André Thierry   Louvet Christophe   Aparicio Thomas   Flesch Michel   Varette Charles   de Gramont Aimery   Group (GERCOR) Oncology  

Cancer Investigation, Vol. 24, Iss. 2, 2006-05 ,pp. : 154-159

Informa Healthcare

Access to resources Recommend Favorite